Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tanezumab in Chronic Low Back Pain
NCT00924664Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in chronic low back pain (CLBP), sponsored by Pfizer. Started Aug 2009; status: terminated.
02
Drugs
tanezumab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00924664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924664.